Biosimilar Newsletter Archive

  1. 08.31.23 -- The Cancer Drug Shortage: When Quality Fails 8/31/2023
    08/31/23 Biosimilar Development Newsletter
  2. 08.30.23 -- Futureproof The Design Of Your Biomanufacturing Capacity 8/30/2023

    08/30/23 Biosimilar Development Newsletter

  3. 08.24.23 -- Key Post-Pandemic Trends In Global FDA Facility Observations 8/24/2023
    08/24/23 Biosimilar Development Newsletter
  4. 08.23.23 -- Mitigating Particulate Risk For Your Injectable Drug Product 8/23/2023

    08/23/23 Biosimilar Development Newsletter

  5. 08.17.23 -- 4 Key Considerations for Onshoring or Nearshoring Drug Production 8/17/2023
    08/17/23 Biosimilar Development Newsletter
  6. 08.10.23 -- Biomanufacturing Process Optimization And Scaling 8/10/2023

    08/10/23 Biosimilar Development Newsletter

  7. 08.10.23 -- Samsung Bioepis Announces Interchangeability Study Results 8/10/2023
    08/10/23 Biosimilar Development Newsletter
  8. 08.03.23 -- FDA Seeks Input On AI Adoption In Drug Development & Manufacture 8/3/2023
    08/03/23 Biosimilar Development Newsletter
  9. 07.27.23 -- 3 Action Items To Mitigate Supply Vulnerabilities 7/27/2023
    07/27/23 Biosimilar Development Newsletter
  10. 07.24.23 -- mAbs On The Express Lane 7/24/2023

    07/24/23 Biosimilar Development Newsletter